SMAD2 and prostate carcinoma: WWP1 negatively regulates the TGF-β tumor suppressor pathway by targeting components like Smad2 and TβRI for ubiquitination and degradation, thereby enhancing prostate cancer (PCa) cell proliferation (Massagué and Like, 1985).